Graham Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Graham Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-55,218	Closed	-$126K	–	1396
2024 Q2	$126K	Buy	55,218 +35,942	+186%	+$137K	﹤0.01%	917
2024 Q1	$83.3K	Buy	+19,276	New	+$67.2K	﹤0.01%	985
2023 Q3	–	Sell	-55,805	Closed	-$139K	–	1347
2023 Q2	$139K	Buy	+55,805	New	+$152K	﹤0.01%	864
2022 Q4	–	Sell	-94,340	Closed	-$1.18M	–	1419
2022 Q3	$1.18M	Buy	+94,340	New	+$1.08M	0.05%	412
2022 Q2	–	Sell	-15,741	Closed	-$119K	–	1297
2022 Q1	$119K	Buy	+15,741	New	+$149K	﹤0.01%	857

Graham Capital Management's GTHX Position: Q3 2024 in Review

Graham Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 55,218 shares — an estimated $126K sold.

Graham Capital Management first reported a position in GTHX in Q1 2022 and held it in 5 quarters. The position peaked at $1.18M in Q3 2022. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Graham Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Graham Capital Management sold 55,218 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $126K.
Graham Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Graham Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $1.18M in Q3 2022.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Graham Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.